A new manager comes aboard. Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted ...

A complementary pair of subadvisors. Our research team assigns Bronze ratings to strategies they’re confident will outperform a relevant index, or most peers, over a market cycle on a risk ...

The pharmaceutical industry officially enters the annual shareholders' meeting season this week. Companies transitioning to management by the second and third generations of founders are drawing ...